Rating History for Oramed Pharma (ORMP) by Cantor Fitzgerald
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/12/2023 | Charles C. Duncan | Downgrade | Neutral (Overweight) |
5.00 (N/A) |
10.79 (3.29) |
-69.51% | Details |
 |
|||||||
